Research on Tap: Drug Repurposing and Reformulation: Opportunities, Risks, and Challenges (2016)
Hosted by Avi Spira, Professor of Medicine, Pathology & Laboratory Medicine, and Bioinformatics; Chief, Division of Computational Biomedicine; and Director, Boston University Cancer Center.
Developing new medicines is a costly, complex, and time-consuming process. Drug repurposing – the application of one compound or agent already used to treat a disease or condition to treat other illnesses – is gaining popularity as a potential solution to the barriers of medicine innovation. However, complex issues such as intellectual property rights for repurposed and re-discovered drugs, fear of discovery of adverse side effects, and others continue to deter many drug manufacturers and researchers. In this session, faculty from across the University discussed their work in this area. View program here.
Note: Videos in slides will not play